Non-Hodgkin Lymphoma | Specialty

The OncLive Non-Hodgkin Lymphoma condition center page is a comprehensive resource for clinical news and expert insights on various types of non-Hodgkin lymphoma, including diffuse large B-cell lymphoma, follicular lymphoma, chronic lymphocytic leukemia, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in non-Hodgkin lymphoma.

Safety and Efficacy of CAR T Therapy in R/R DLBCL

January 30th 2020

Use of CAR T Therapy in R/R DLBCL

January 30th 2020

Treatment Alternatives to Chemotherapy in R/R DLBCL

January 30th 2020

Management of Relapsed/Refractory DLBCL

January 30th 2020

Role of CNS Prophylaxis in DLBCL

January 30th 2020

Optimization of PET Scans and Determining Relapse in DLBCL

January 30th 2020

Comorbidities and Role of R-CHOP in DLBCL

January 30th 2020

Prognostic Factors in DLBCL

January 30th 2020

Treatment of Newly Diagnosed DLBCL

January 30th 2020

The Future Landscape of Follicular Lymphoma Treatment

January 28th 2020

Phase Ib Polatuzumab Vedotin Trial

January 28th 2020

The Phase III GADOLIN Trial

January 28th 2020

Previously Untreated FL: Obinutuzumab Plus Lenalidomide

January 28th 2020

The Phase II EZH2 Inhibitor Trial

January 28th 2020

Sequencing Strategies for Later-Line Therapy

January 28th 2020

The DYNAMO Later-Line Regimen

January 28th 2020

Treatment Options After Second-Line Relapse

January 28th 2020

Relapsed/Refractory Treatment: The MAGNIFY Regimen

January 28th 2020

Determining Second-Line Therapy in FL

January 28th 2020

Phase III GALLIUM Results and Maintenance Therapy

January 28th 2020